Announce Date | 05/12/2025 |
EPS Normalized Actual | $-0.12 (Miss by $-0.02) |
EPS GAAP Actual | $-0.12 (Miss by $-0.02) |
Revenue Actual | $0.027511B |
Revenue Surprise | Beat by $27.511M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.03 |
EPS GAAP Estimate | $-0.03 |
Revenue Estimate | $0.033367333B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0 | INF | 0 | 0 | 1 |
Dec 2027 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.03 | 0.02 | 0.027511B | -16.72% | -5.49M |
FQ4 2024 (Dec 2024) | -97.17 | -97.1 | 29.469B | 99.88% | 29435.99M |
FQ3 2024 (Sep 2024) | -0.11 | -0.11 | 0.029439B | -15.52% | 29.44M |
FQ2 2024 (Jun 2024) | -0.095 | -0.095 | 0.029246B | -12.3% | 29.25M |
FQ1 2024 (Mar 2024) | 0.39 | 0.39 | 0.032112B | 1.82% | 32.11M |
FQ4 2023 (Dec 2023) | -0.39 | -0.39 | 0.034265B | 100% | 34.27M |
FQ3 2023 (Sep 2023) | -0.11 | -0.11 | 0.034009B | 100% | 34.01M |
FQ1 2021 (Mar 2021) | 0.0027 | 0.0027 | 0B | NAN% | 0M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.03
Consensus Revenue Estimates
0.033367333B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 0 | -- | 0 | 0 | 1 |
FQ2 2028 (Jun 2028) | 0 | -- | 0 | 0 | 1 |
FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 1 |
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
FQ3 2026 (Sep 2026) | -0.04 | -- | -0.04015497 | -0.03976534 | 1 |
FQ2 2026 (Jun 2026) | -0.045 | -- | -0.04517434 | -0.04473601 | 1 |
FQ1 2026 (Mar 2026) | -0.045 | 33.33 | -0.04517434 | -0.04473601 | 1 |
FQ4 2025 (Oct 2025) | -0.026667 | -364282.95 | -0.02743292 | -0.02616213 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ2 2028 (Jun 2028) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ1 2028 (Mar 2028) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ3 2027 (Sep 2027) | 0.03B | -- | 0.03B | 0.03B | 2 |
FQ2 2027 (Jun 2027) | 0.02B | -- | 0.02B | 0.03B | 2 |
FQ1 2027 (Mar 2027) | 0.03B | -- | 0.03B | 0.03B | 2 |
FQ3 2026 (Sep 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ2 2026 (Jun 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
FQ1 2026 (Mar 2026) | 0.03B | -2.25 | 0.03B | 0.03B | 2 |
FQ4 2025 (Oct 2025) | 0.03B | -84339.2 | 0.03B | 0.04B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.05 | -0.03 | 0.02 | -66.67% |
FQ4 2024 (Dec 2024) | -0.07 | -97.17 | -97.1 | 99.93% |
FQ3 2024 (Sep 2024) | -0.11 | -0.11 | 100% | |
FQ2 2024 (Jun 2024) | -0.095 | -0.095 | 100% | |
FQ1 2024 (Mar 2024) | 0.39 | 0.39 | 100% | |
FQ4 2023 (Dec 2023) | -0.39 | -0.39 | 100% | |
FQ3 2023 (Sep 2023) | -0.11 | -0.11 | 100% | |
FQ1 2021 (Mar 2021) | 0.0027 | 0.0027 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.03B | $0.03B | $-5.49M | -19.95% |
FQ4 2024 (Dec 2024) | $0.03B | $29.47B | $29435.99M | 99.89% |
FQ3 2024 (Sep 2024) | $0B | $0.03B | $29.44M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.03B | $29.25M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.03B | $32.11M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.03B | $34.27M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.03B | $34.01M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |